OSR Holdings, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed on October 13, 2025, by OSR Holdings, Inc. (NASDAQ: OSRH), a Delaware corporation. The filing discloses the entry into a Material Definitive Agreement on October 13, 2025, wherein OSR Holdings Co., Ltd. ("OSRK"), a wholly-owned subsidiary of the Company, agreed to acquire Woori IO Co., Ltd. ("WORIO").
Key Financial Metrics and Transaction Details
- Transaction Value: Approximately KRW 15 billion (USD 10.6 million).
- Consideration: OSRK will issue 84,338 new shares to existing WORIO shareholders in exchange for 88,891 WORIO shares.
- Exchange Ratio: 0.948832 OSRK shares for each WORIO share.
- Target Profile: WORIO is a South Korea-based medical device company developing non-invasive biosensing technology (NIRS) for glucose monitoring.
- Strategic Partnership: WORIO is currently providing technical development services to Samsung Electronics under a Non-invasive Blood Glucose Monitor PoC Development Services Agreement. Specific funding amounts from Samsung are undisclosed due to confidentiality.
Material Changes and Conditions
The acquisition is subject to customary closing conditions, including shareholder approval by WORIO (target meeting date: December 19, 2025) and regulatory clearances. The effective date of the share exchange is expected to be January 12, 2026. Upon closing, WORIO will become a wholly-owned subsidiary of OSRK and indirectly of OSR Holdings, Inc.
Outlook, Contingencies, and Unusual Items
Contingent Equity Conversion: Under Annex 2 of the Agreement, if OSR Holdings' common stock reaches USD 10.00 per share on NASDAQ within three years after closing, former WORIO shareholders may exchange their OSRK shares for OSR Holdings Inc. common stock at a ratio of 12.96 OSRH shares for each OSRK share. This conversion is subject to applicable U.S. securities laws and Board approval.
Regulatory Disclosure: The Company issued a press release on October 14, 2025, regarding this agreement (Item 7.01). Certain portions of the Share Exchange Agreement were omitted from the public filing to prevent competitive harm but will be furnished to the SEC upon request.
Investor Verification Checklist
- Verify the status of WORIO's shareholder approval meeting scheduled for December 19, 2025.
- Monitor regulatory clearance progress for the cross-border acquisition in South Korea and the U.S.
- Track OSR Holdings' stock price relative to the USD 10.00 threshold for the contingent equity conversion.
- Review the press release (Exhibit 99.1) for additional strategic context regarding the integration of WORIO's NIRS technology.
- Note that specific financial details regarding WORIO's funding from Samsung are not disclosed in this filing.